A pioneer in gene therapy, Dr. Bennett has been at the forefront of translational study for decades.  Given her experience as a scientific founder for multiple biotechnology companies, she understands the critical role that a successful translational center could play in allowing new technology to mature rapidly but cautiously through proof-of-concept studies, pharmacologic/toxicological testing, clinical trials, and eventual commercialization. Under her leadership, CAROT prides itself in being a streamlined, integrated incubator that nurtures nascent projects from both academic and commercial communities.